| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/22/2003 | EP1277053A1 Device and process for lateral flow saliva testing |
| 01/22/2003 | EP1277052A1 Device for detecting analytes related to sample ph |
| 01/22/2003 | EP1277051A1 Reservoir monitoring |
| 01/22/2003 | EP1277050A2 Method of determining the three-dimensional shape of a macromolecule |
| 01/22/2003 | EP1277049A1 Gas sensor assembly and method |
| 01/22/2003 | EP1277047A1 Sensor element operated with a preliminary catalysis |
| 01/22/2003 | EP1276907A2 Viral vectors for use in monitoring hiv drug resistance |
| 01/22/2003 | EP1276904A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276900A2 Integrated systems and methods for diversity generation and screening |
| 01/22/2003 | EP1276897A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276892A2 A bacterial two-hybrid system for protein interaction screening |
| 01/22/2003 | EP1276879A1 MUIR-TORRE-LIKE SYNDROME IN Fhit DEFICIENT MICE |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276865A2 Methods for binding an exogenous molecule to cellular chromatin |
| 01/22/2003 | EP1276864A1 Primer for diagnosis of one or more kinds of cancer |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276771A1 Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample |
| 01/22/2003 | EP1276770A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 01/22/2003 | EP1276769A1 New neuromedin u receptor nmur2 and nucleotides encoding it |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276761A2 New bromodomain protein |
| 01/22/2003 | EP1276760A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 01/22/2003 | EP1276757A1 ANTIGENIC PEPTIDE FRAGMENTS OF VapA PROTEIN, AND USES THEREOF |
| 01/22/2003 | EP1276753A2 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease |
| 01/22/2003 | EP1276752A2 Method of evaluating a risk of a subject of developing vascular complications |
| 01/22/2003 | EP1276702A2 Compositions and methods for detecting and quantifying gene expression |
| 01/22/2003 | EP1276555A2 A method of fabricating coded particles |
| 01/22/2003 | EP1276503A2 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 01/22/2003 | EP1276500A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 01/22/2003 | EP1276412A1 Method and device for sampling and analyzing interstitial fluid and whole blood samples |
| 01/22/2003 | EP1276379A1 In situ growth, freezing and testing of cultured cells |
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/22/2003 | EP1179183A4 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 01/22/2003 | EP1173771A4 Procoagulant assay |
| 01/22/2003 | EP1151138A4 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 01/22/2003 | EP1101108B1 Method for determining the shade stability of lacquers |
| 01/22/2003 | EP1095277B1 A system for cell-based screening |
| 01/22/2003 | EP1051510A4 A rapid method for the assessment of the inhibition and kill of anaerobic bacteria by toxic compounds |
| 01/22/2003 | EP1021724B1 Assays and probes with enzyme labels |
| 01/22/2003 | EP1005633A4 A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method |
| 01/22/2003 | EP0980517A4 Detachable-element assay device |
| 01/22/2003 | EP0929807B1 Method and device for measuring painted test tables |
| 01/22/2003 | EP0886754B1 Non-competitive immunoassay with blocking of unoccupied specific binding sites on solid phase |
| 01/22/2003 | EP0873423A4 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 01/22/2003 | EP0871699B1 Method of making an alcoholic beverage by fermentation, and fermentation test kit for use in the method |
| 01/22/2003 | EP0853679B1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 01/22/2003 | EP0842427B1 Screening assay for k+ channel agonists |
| 01/22/2003 | EP0756709B1 Method of selection of a population or subpopulation of a sample |
| 01/22/2003 | EP0653067B1 Method and kit for pyridinium crosslink assay |
| 01/22/2003 | EP0632892B1 Fast response test panel |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | CN2532490Y Tumor abnormity protein test system |
| 01/22/2003 | CN2532489Y Microscopic instrument with multiple urinary sediment counting container |
| 01/22/2003 | CN2532488Y Concrete expansion/contraction tester |
| 01/22/2003 | CN1392956A Quantitative measuring method and apparatus of metal phase using X-ray diffraction method, and method for making plated steel sheet using them |
| 01/22/2003 | CN1392772A Animal showing schizophrenia-like abnormality in coagnitive behaviors and method of construction same |
| 01/22/2003 | CN1392415A Powder included water elutrating instrument and its operation process |
| 01/22/2003 | CN1392414A Method for analyzing and studying high temperature foaming of metallurgical cinder |
| 01/22/2003 | CN1392401A Fast detector for milk component |
| 01/22/2003 | CN1392259A CR1 gene ralative to cell reconstitution, conduction and death |
| 01/22/2003 | CN1099652C Belongness judging device |
| 01/22/2003 | CN1099596C Method for detecting exogenous origin gene integrator animal embryon |
| 01/22/2003 | CN1099595C Two-dimensional sensor having photoconductive layer for measuring cell activity and measuring system for the same purpose |
| 01/22/2003 | CN1099586C Method of determining cause of defects on steel material surface |
| 01/22/2003 | CN1099465C Ovulation-testing reagent kit for natural contraception and its making method |
| 01/21/2003 | WO2002008756A1 Method of differentiating dementing diseases |
| 01/21/2003 | US6510330 Method and device for measuring blood parameters |
| 01/21/2003 | US6510263 Waveguide plate and process for its production and microtitre plate |
| 01/21/2003 | US6509514 Chimeric animal model susceptible to human hepatitis C virus infection |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509383 Metal charged iminodiacetic acid (IDA) cellulose for detecting a test sample having a histidine tag. The present invention also provides methods for determining cloned protein expression and function. handling of denatured proteins with |
| 01/21/2003 | US6509316 Administering therapeutically effective amount of inhibitor of phospholipase A2 to animal |
| 01/21/2003 | US6509196 Compensation for non-specific signals in quantitative immunoassays |
| 01/21/2003 | US6509194 The method comprises detecting radiation from excited imidogen radicals (NH*) generated from the gas sample correlating to ammonia concentration in sample |
| 01/21/2003 | US6509192 Method to increase the system quality control capabilities of hematology instruments |
| 01/21/2003 | US6509187 Method and device for collection and preparation of tissue samples for molecular genetic diagnostics |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509170 Polynucleotides encoding human tumor necrosis factor delta |
| 01/21/2003 | US6509169 Detection of Helicobacter pylori |
| 01/21/2003 | US6509168 Detection of preferential particles in sample; liquify sample, pour into plate, incubate in wells, monitor wells and detect preferential particles |
| 01/21/2003 | US6509167 High throughput sarcomeric assay |
| 01/21/2003 | US6509166 Detection is accomplished by growing the target analyte in a nutrient medium so as to form colonies of the target analyte in the medium, and then visually detecting and counting any resultant target analyte colonies |
| 01/21/2003 | US6509165 Detecting the ability of proinsulin peptide to preferentially stimulate the T-cells of diabetic subjects by measuring the ability of the T-cells to proliferate or ability of the T-cells to produce cytokines |
| 01/21/2003 | US6509164 Liquid specimen container and attachable testing modules |
| 01/21/2003 | US6509162 Methods for selectively modulating survivin apoptosis pathways |
| 01/21/2003 | US6509161 Distinguishing between fluorescent light emitted by green fluorescent protein and fluorescent light emitted by other auto-fluorescent molecules; in yeast where green fluorescent protein is expressed in response to DNA damage |
| 01/21/2003 | US6509158 Nucleic acid molecule is elongated and fixed along its length onto a solid planar surface so that said nucleic acid molecule is individually analyzable and accessible for enzymatic reactions |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509056 Impregnated with liquids which harden within concrete pores and microcracks, and develop a sharp contrast with the body of concrete in microscopic images. |
| 01/21/2003 | US6509019 Immunologically active proteins from Borrelia burgdorferi |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |